MedPath

Investigating the effect of using cinnamon supplements on IVF cycle results in infertile women with polycystic ovary syndrome

Phase 3
Recruiting
Conditions
Polycystic ovarian syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20080831001141N44
Lead Sponsor
otus Royan Charitable Fundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

Infertile women with polycystic ovary syndrome (PCOS) diagnosed according to the Rotterdam criteria who meet at least 2 of the following three criteria including: (1) oligomenorrhea or anovulation, (2) hyperandrogenism (clinical or biochemical ng/ dL 80 = serum T level), (3) the presence of polycystic ovaries in ultrasound).
The age range of 18 to 38 year.
Written consent to participate in the study

Exclusion Criteria

Body mass index above 35 kg/m2
Endocrine disorders including diabetes mellitus, hyperprolactinemia, hypertension, Cushing's syndrome
Autoimmune disorders
History of recurrent pregnancy loss
Genital, ovarian or uterine abnormalities
Hydrosalpinx diagnosis
Congenital adrenal hyperplasia, androgen-producing tumors or acromegaly
Sensitivity to cinnamon
Daily and frequent consumption of cinnamon to treat infertility
Severe male factor infertility
Moderate to severe endometriosis diagnosis
Use of other hypoglycemic, insulin-sensitizing drugs (e.g. Metformin) or other antioxidant supplement (e.g. Myo-inositol) and ß-blocker before or during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath